|
|
|
17.03.26 - 22:06
|
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year (Business Wire)
|
|
|
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of experience at the company, most recently as Aptar Pharma President, has been appointed President and Chief Executive Officer, effective September 1, 2026. He will succeed Stephan B. Tanda, who has served as President and Chief Executive Officer since 2017. Stephan is expected to continue to work closely with Gael and the Board as an advisor through the end of the year to help ensure a seamless transition as the company enters its next phase of growth. Stephan intends to retire from Aptar's Board by the end of 2026 and the Board will appoint Gael as a director on September 1, 2026.
“Gael has played a pivotal role in shaping Aptar Pharma's strategic direction, expanding our technologies and services to support customers from formulation to patient. Hi...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
05.02.26 - 23:03
|
Aptar Reports Fourth Quarter and Annual 2025 Results (Business Wire)
|
|
|
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended December 31, 2025, as compared to the corresponding period of the last fiscal year.
Fourth Quarter 2025 Highlights
(Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures)
Reported sales increased 14% and core sales increased 5%—all three segments delivered core sales growth
Reported net income decreased 26% to $74 million and reported earnings per share decreased 24% to $1.13
Adjusted earnings per share were $1.25
Adjusted EBITDA margin was 19.8% compared to 23.0% in the prior year
Returned $206 million to shareholders through share repurchases and dividends
Subsequent to the quarter, the Board of Directors has approved a new authorization for the repurchase of up to $600 million of the Company's comm...
|
|
|
|
|
22.01.26 - 23:09
|
Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details (Business Wire)
|
|
|
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is February 25, 2026, to stockholders of record as of February 4, 2026.
As previously announced, Aptar will hold a conference call on Friday, February 6, 2026, at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. A replay of the conference call can also be accessed for a limited time on the Investors page of the website.
Annual Meeting
The Board also approved the 2026 Annual Meeting of Stockholders to be held virtually on May 6, 2026, at 9:00 a.m. Central Time. The record date for stockholders entitled to vote at the meeting is March 13, 2026. Mo...
|
|
|
|
|
|
|
07.01.26 - 23:06
|
Aptar Announces 2026 Quarterly Conference Call Dates (Business Wire)
|
|
|
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.
Quarterly Conference Calls
Press Release(1)
Conference Call(2)
4th Quarter and Annual 2025 Results
February 5, 2026
February 6, 2026, at
8:00 a.m. CT
1st Quarter 2026 Results
April 30, 2026
May 1, 2026, at
8:00 a.m. CT
2nd Quarter 2026 Results
July 30, 2026
July 31, 2026, at
8:00 a.m. CT
3rd Quarter 2026 Results
October 29, 2026
October 30, 2026, at
8:00 a.m. CT
(1)
Press releases will be issued on the dates noted after the close of trading on the New York Stock Exchange.
(2)
Times shown are in the Central U.S. time zone. Conference calls will last approximately one hour and interested parties are invited to listen to a live webcast by visiting investors.aptar.com. Replay ...
|
|
|
|
|
05.01.26 - 23:06
|
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 (Business Wire)
|
|
|
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced its participation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026.
Stephan Tanda, President and CEO, will present at 11:15 a.m. Eastern Standard Time. Vanessa Kanu, Executive Vice President and CFO and Gael Touya, President Aptar Pharma, will also be available.
A live audio webcast and presentation materials will be available in the "Investors" section of the Company's website at www.aptar.com.
About Aptar
Aptar is a global leader in drug delivery and consumer product, dispensing, dosing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world's leading brands, Aptar in t...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
